The Colorado BioScience Association Celebrates Ten Years At November 7th Event

Colorado BioScience Association (CBSA) will be celebrating its 10th anniversary at the Annual Awards Dinner, Thursday, November 7, 2013, 5:30 to 9:00 pm, at the Denver Marriott City Center. The announcement is made by April Giles, President and CEO of the Colorado BioScience Association (CBSA) who says, “Over the past 10 years the Association has grown from a small startup enterprise to a mature and successful organization. This is our night to celebrate and honor our community.”

Three key leaders who have made significant contributions to the industry and community in Colorado will be sharing their memories, insight and vision.

* Larry Gold, Ph.D., Founder and CEO, SomaLogic, and Professor at the University of Colorado Boulder
* Chris Christoffersen, Ph.D., General Partner, Lightstone Ventures & Partner, Morgenthaler Ventures
* David Perez, President and Chief Executive Officer, Terumo BCT, Chairman, Blood Management Business Division, Terumo Corporation

This year’s event will feature three very special honors given only for the 10th anniversary, including the Pioneering Award, Founders Award and Visionary Award. The awardees will be announced on stage by emcee Steffan Tubbs, Morning Co-Host on 850 KOA News.

* The Pioneering Award will be given to individuals who have led the bioscience industry in Colorado from the ground up. These leaders have made significant contributions to the industry and the community as a whole.

* The Founders Award will be given to organizations that have shaped CBSA over the past 10 years. Through their leadership and support CBSA has been able to succeed and serve the industry.

* The Visionary Award will be given to one bioscience leader who looks ahead and continues to build the bioscience industry in the future.

The evening will also honor the 2013 Class of Boettcher Investigators of the Webb-Waring Biomedical Research Program, plus the outstanding annual company and individual awards.

Link to the Business Wire release

Link to the PitchEngine Social Media newswire

The Conservation Fund: 'Putting Yellow Perch Back On The Menu'

Quoting from The Conservation Fund's October 8th Common Ground Newsletter:

"While the Indiana Soybean Alliance worked with Bell Aquaculture to develop soy-based feed for farm-raised Bell Perch®, our Freshwater Institute developed a land-based, closed fish farming system that uses just a small amount of water, requires no antibiotics and captures water waste to fertilize soybean fields. It’s a winning solution that offers economic and conservation benefits, while putting yellow perch back on the menu for fish lovers across the region."

Link to TCF Common Ground

Link to the full article 'Sustainable Fish Success In Indiana'

Also read "Face Of This Place: Norman McCowan, President Of Bell Aquaculture In Indiana"

Quoting from the interview with Bell Aquaculture President Norman McCowan:

"You run one of the most successful aquaculture companies in the nation, how did you get interested in aquaculture?

In the mid-80’s, I raised bait fish. This was my hobby and passion; I didn’t realize it at the time, but that was aquaculture. Learning the water chemistry and fish husbandry in an effort to keep bait fish alive so that I could trout line Indiana’s Wabash River was my first step into aquaculture. At this point I was working in the automotive industry where I really learned about efficiency. I was approached for some consulting work for Bell Aquaculture because I knew about fish husbandry and eventually was hired on full time. My drive to push efficiency into the business and my passion to expand aquaculture is ultimately what led me to be named as president and COO in 2010."

'Making Land-based Aquaculture more Sustainable'

Quoting from The Fish Site today:

"Earlier this month, an International symposium brought together people from 15 countries to discuss how to improve land-based aquaculture, including its performance, sustainability, and cost of raising salmon and other fish...

...'For the first time this industry is seeing a technology that is scalable and gets a return on investment,' said Norman McCowan, President, Bell Aquaculture. The Freshwater Institute designed a closed-containment system for Bell to raise its signature perch on land that conserves water, reduces fertilizer use and provides chemical- and pesticide-free healthy fish for human consumption."

Link to The Fish Site

Video First Look: 2013 Rocky Mountain Life Science Investor and Partnering Conference

Clovis Oncology CEO Pat Mahaffy: 'We're In A Good Cycle Now'
http://youtu.be/staaQJiKQOI

Array BioPharma CEO Ron Squarer: 'Advantages of Colorado'
http://youtu.be/DQHF0GXEvm8

Jeff Calcagno, MD, with J&J Development Corp: 'I'll Tell You What We're Looking For'

http://youtu.be/zoZcoJaAEsQ

A video selection of the thirty regional presenting companies:

Ventria Bioscience, Fort Collins, CO: http://youtu.be/TH9piHw6OVw
AmideBio, Louisville, CO: http://youtu.be/KzxEK4b81rk
Renaptys Vaccines, Aurora, CO: http://youtu.be/If9tda2AD_Q
Sinopsys Surgical, Boulder, CO: http://youtu.be/9MQIl5BiRqI
FitBionic, Boulder, CO: http://youtu.be/vIuWVZPdtB0
Xenograft, Missoula, MT: http://youtu.be/jndn0pk1gPw
Wasatch Microfluidics, Salt Lake City, UT: http://youtu.be/-6QQGzmRuU8
Neuro Assessment Systems, Littleton, CO: http://youtu.be/3oC8a_LdAF4
NASSEO, Peoria, AZ: http://youtu.be/rx4WcCJ9HXY

CBSA Pres/CEO April Giles - Thanks to the RMLIPC Regional Sponsoring Organizations

http://youtu.be/_UNh2aDFKs8

Fitzsimons Redevelopment Authority Pres/CEO Steve VanNurden Welcoming Remarks RMLIPC Opening Reception

http://youtu.be/KhW6vgfLsZI

Link to the conference webpage

CBSA partners with two of the State’s Economic Development Entities to Promote Colorado’s Strengths at AdvaMed 2013

Representatives from the Colorado BioScience Association (CBSA), the Colorado Springs Regional Business Alliance and the Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostic sectors during 'AdvaMed 2013: The MedTech Conference,' September 23-25, in Washington, D.C. The announcement is made by April Giles, CBSA President and CEO, who says more than 1,000 industry experts and thought leaders will participate in over 40 educational panels and executive workshops during the event, including the following CBSA members:

Metro Denver Economic Development Corporation, http://www.metrodenver.org
Colorado Springs Regional Business Alliance, http://www.coloradospringsbusinessalliance.com

Baxter International Inc., http://www.baxter.com  

Cardinal Health, http://www.cardinal.com
CEA Medical Manufacturing, http://www.ceatechnologies.com
Covidien, http://www.covidien.com
C. R. Bard, Inc., http://www.bardmedical.com  

DePuy Synthes, http://www.depuysynthes.com

EY, http://www.ey.com

Johnson & Johnson, http://www.jnj.com               

MBio Diagnostics, Inc., http://www.mbiodx.com

Medtronic, http://www.medtronic.com  

Silicon Valley Bank, http://www.svb.com               

Society of Physician Entrepreneurs (SoPE), http://www.sopenet.org

St. Renatus, LLC, http://www.st-renatus.com       

Terumo BCT, http://www.terumobct.com             

The Conafay Group, http://www.conafaygroup.com          

“This will be the CBSA’s seventh year participating in the AdvaMed Conference and each year the potential connections and opportunity to showcase Colorado’s medical device and diagnostic industries becomes even more abundant,” said Giles. “Over the last five years Colorado technology and companies have received over $600 million in investment capital and the life science community is garnering national attraction for its continued success. We also continue to be ranked as the 6th largest medical device cluster in the nation with over 340 medical device, diagnostic and instruments companies. Colorado is positioned as a leader in this sector and this conference provides us an opportunity to promote the state.”

Link to the Business Wire Release

Link to the PitchEngine Social Media Release

Coverage: CBSA's Rocky Mountain Life Science Investor and Partnering Conference 2013

Quoting: "The vetted companies came from Colorado, Arizona, Utah, New Mexico and Montana with hopes of attracting investment to move their products – focused on cancer, multiple sclerosis, diabetes, Lyme disease, wound repair and a host of other bioscience challenges – toward commercialization and profitability.

The day-long conference kicked off with a breakfast keynote “fireside chat” featuring Kyle Lefkoff, founder of Boulder Ventures, moderating a discussion with the leaders of two of Colorado’s premier publicly traded life science companies – Patrick Mahaffy, CEO and co-founder of Clovis Oncology and Ron Squarer, CEO of Array BioPharma, who shared their views on the state of Colorado’s bioscience industry"

Link to the posting

Quoting: "Executives of two Boulder-based biopharmaceutical companies said Thursday that early-stage pharma business in Colorado is hampered by the lack of a stable core that can be built around. Speaking at the Rocky Mountain Life Science Investor and Partnering Conference at the Ritz-Carlton, the two said they do their best in an environment that can be at once frustrating and invigorating."

Link to the posting

30+ Life Science Investors & Strategic Partners Convene In Denver This Week For 2013 Rocky Mountain Life Science Investor & Partnering Conference

More than thirty of the industry’s leading investors and strategic partners will attend presentations by the region’s most innovative life science companies at the 2013 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), September 18-19 at the The Ritz-Carlton, Denver.

The announcement is made by April Giles, President & CEO of the Colorado BioScience Association (CBSA) who says, “Leading biotech, medical device, diagnostic and pharmaceutical investors from across the country will be coming to Denver to connect and invest in the regions emerging life science companies. Each company will make a 10-minute presentation to an audience of their peers, investors and partners, followed by a 5-minute period of questions—this type of high-pressure pitching is typical in vying for highly coveted VC funding.”

“The RMLIPC really showcases the best companies from the region and provides investors an opportunity to evaluate these fresh investment opportunities and meet one-on-one with their founders and executive team,” said Giles. “It’s important to note, the Rocky Mountain region is a key player in the life science industry. There has been over $1 billion in investment in the region over the past five years.”

The following investors and strategic partners will be attending RMLIPC 2013: 

Amgen Ventures, Thousand Oaks, CA - http://www.amgen.com/partners/amgen_ventures

Aphelion Capital, Mill Valley, CA - http://www.aphelioncapital.net  

Bay City Capital, San Francisco, CA - http://www.baycitycapital.com

BioGenerator, St. Louis, MO - http://www.biogenerator.org  

Boulder Ventures, Boulder, CO - http://www.boulderventures.com  

Charter Life Sciences, Santa Clara, CA - http://www.charterls.com  

Covidien, Mansfield, MA - http://www.covidien.com

Epic Ventures, Albuquerque, NM - http://www.epicvc.com

GE Healthcare Financial Services, Chicago, IL - http://www.gehealthcarefinance.com

Goodworks Ventures, MT - http://www.goodworksventures.com

High Country Venture, Boulder, CO - http://highcountryventure.com  

Johnson & Johnson Development Corporation, New Brunswick, NJ - http://www.jjdevcorp.com  

KMG Capital Partners, Denver CO

Level 5 Partners, Fort Collins, CO - http://l5partners.com  

Lightstone Ventures, Boulder, CO - http://lightstonevc.com  

Mercury Fund, Houston, TX - http://www.mercuryfund.com  

Mile High Fund, Denver, CO - http://www.comilehighfund.com  

Morgenthaler Ventures, Menlo Park, CA  - http://www.morgenthaler.com  

New Enterprise Associates, Menlo Park, CA - http://www.nea.com  

Novartis Venture Funds, Cambridge, MA - http://www.venturefund.novartis.com  

Red Script Ventures, New Brunswick, NJ - http://www.jjdevcorp.com

Remeditex, Dallas, TX - http://remeditex.com  

Salt Lake Life Science Angels, Salt Lake City, UT - http://www.sllsa.com 

Sanderling Ventures, San Mateo, CA - http://www.sanderling.com  

Signal Peak Ventures, Salt Lake City, UT - http://signalpeakvc.com     

Silicon Valley Bank, Broomfield, CO - http://www.svb.com

Split Rock Partners, Menlo Park, CA - http://www.splitrock.com  

SR One, Corporate VC Arm of GlaxoSmithKline, San Francisco, CA - http://www.srone.com

Volcano Capital, New York, NY - http://www.volcanocap.com  

Wayne Brown Institute, Salt Lake City, UT - http://www.waynebrowninstitute.org  

Wexford Capital LP, Greenwich, CT - http://www.wexford.com  

About the Rocky Mountain Life Science Investor & Partnering Conference 

The 2013 Rocky Mountain Life Science Investor & Partnering Conference – spearheaded by the Colorado BioScience Association in collaboration with associations in Arizona, Montana, New Mexico and Utah — will open with a reception at the Colorado Governor’s Mansion September 18th and follow with a full day of company pitch presentations September 19th. The keynote breakfast will include Kyle Lefkoff, founder and General Partner of Boulder Ventures, leading a conversation with the CEOs of Colorado's two premier publicly-traded pharmaceutical companies-Patrick Mahaffy, Founder and CEO of Clovis Oncology and Ron Squarer, CEO of Array BioPharma. The keynote lunch titled “New Approaches to Healthcare Innovation” will be a presentation from Jeff Calcagno, M.D., Venture Investments with Johnson & Johnson Development Corporation. For more information and registration details, visit http://www.RockyMtnBioInvest.com.

On Twitter, please use the hashtag #RockyMtnBioInvest for your tweets.